Jewish Reporter a Publication of the Flint Jewish Federation

Total Page:16

File Type:pdf, Size:1020Kb

Jewish Reporter a Publication of the Flint Jewish Federation Jewish Reporter A Publication of the Flint Jewish Federation VOLUME. 72 NO. 4 APRIL 1, 2021, 19 NISAN 5781 VOLUME. 72 NO. 4 VVAT, 5777 APRIL 1, 2021, 19 NISAN 5781 IS PUBLISHED WILL YOU LEAVE A LEGACY? MONTHLY BY THE Flint Jewish Federation Every five years. You should review your will and estate plan every five years to 5080 West Bristol Rd. Ste.3 make sure it still expresses your wishes. Has it been a while? Or have you recently Flint, MI 48507 updated your estate plan? Did you leave a legacy to the Flint Jewish community— Office: 810-767-5922 Fax: 810-767-9024 TBE, CBI, the Federation, Machpelah Cemetery or Chabad? Email: [email protected] If you did let us know by completing and submitting a Letter of Intent. You don’t Website: flintfed.com need to share the amount if you don’t want to but let us know if you made a gift by will, life insurance policy, pension fund, or some other means and to whom. Any of our Steven C. Low Jewish Institutions that has 18 Letters of Intent submitted will earn a $5000 gift from Executive Director the Harold Grinspoon Foundation. Sheryl Deutsch You don’t have to pay anything right now—just fill out the form, submit it and within President the year formalize the gift. If you already have formalized the gift then submitting Jeff Himelhoch the Letter is all you need to do for your gift to count. Vice President Federation has already received three Letters. Three families so far have made a commitment to create a legacy to ensure a future flourishing Flint Jewish Community. Diane Lindholm Treasurer In the weeks to come we will share their stories of why they have created a legacy. We hope that when our team member calls you too will share your story and create a Kathy Weiner legacy. Secretary For more information or questions regarding Immediate Past leaving your legacy, please contact Steven President, Russ Deutsch Low, Executive Director, 810.767.5922. Be Remembered Forever by the Flint Board Members Jewish Community with a Gift in Your Rabbi Jeff Ableser Will, Trust, Retirement Account or Life Dr. Seth Bernard Insurance Policy Dr. Stephen Burton Jeff Chimovitz Wendy Flamenbaum Charna Flynn Lynne Hurand 2ND YOM HA'ATZMAUT ACROSS AMERICA Joel Kleiner SUNDAY, APRIL 11, 2:00 PM EST Judy Kasle Christine Meiloch Leonard Meizlish Mark your Calendar! Please plan to join us for the 2nd Yom Ha'atzmaut Across Saroja Reddy Rachel Stern America LIVE concert and fundraiser. FLINT will join with over 70 communities across Ernelle Taylor the country to celebrate Israel’s birthday, and support MAZON featuring top Jewish and Israeli Rabbi Yisroel Weingarten musical artists. To learn more please visit: https://sheldonlow.com/yom-ha-atzmaut-across-america Happy Passover To All Our Friends The Bombel, Heidenrich & Sherman Family 2 INSIDE JEWISH COMMUNITY SERVICES JCS Senior Lunch Program (Subject to Change) Thursday, April 1 NO CONGEGRATE MEAL Monday, April 5 ROSEMARY CHICKEN Tuesday, April 6 GRILL OF INDIA AT TBE/CBI BINGO Thursday, April 8 VEGETABLE SOUFFLE Monday, April 12 SHEPHERD’S PIE Tuesday, April 13 GRILL OF INDIA AT TBE/CBI BINGO Thursday, April 15 GARLIC HERB CHICKEN Monday, April 19 SALMON Tuesday, April 20 GRILL OF INDIA AT TBE/CBI Thursday, April 22 DELI SANDWICHES Monday, April 26 NO CONGREGATE MEAL Tuesday, April 27 GRILL OF INDIA AT TBE/CBI Thursday, April 29 GRILL OF INDIA AT TBE/CBI RSVP to Jamie at [email protected]/810-767-5922 for lunch (24 hour notice) Check with Federation office if lunch program is closed due to inclement weather Temple Beth El, 5150 Calkins Rd. (enter through main door of Temple—MASK is required) Marina Kharlamenko, Immigrant Coordinator, visits Russian Seniors to celebrate Women’s International Day! 3 BIG CHEEKS A grandson of slaves, a boy was born in a poor Russian and Jewish songs. Over time, this boy became the neighborhood of New Orleans known as the "Back of adopted son of this family. The Karnofskys gave him money Town." His father abandoned the family when the child to buy his first musical instrument as was the custom in the was an infant. His mother became a prostitute and the boy, Jewish families. They sincerely admired his musical talent. and his sister had to live with their grandmother. Early in Later, when he became a professional musician and com- life he proved to be gifted for music and with three other poser, he used these Jewish melodies in compositions, kids he sang in the streets of New Orleans. His first gains such as St. James Infirmary and Go Down Moses. The little were coins that were thrown to them. A Jewish family, black boy grew up and wrote a book about this Jewish fami- Karnofsky, who had emigrated from Lithuania to the USA, ly who had adopted him in 1907. In memory of this family had pity for the 7-year-old boy and brought him into their and until the end of his life, he wore a Star of David and home. Initially giving 'work' in the house, to feed this hungry said that in this family, he had learned "how to live real child. There he remained and slept in this Jewish family's life and determination. "You might recognize his home where, for the first time in his life, he was treated with name. This little boy was called: Louis "Satchmo" kindness and tenderness. When he went to bed, Mrs. Armstrong. Louis Armstrong proudly spoke fluent Karnovsky sang him a Russian lullaby that he would sing Yiddish! And "Satchmo" is Yiddish for "Big Cheeks"!!! with her. Later, he learned to sing and play several WARM PASSOVER GREETINGS FROM ERNELLE TAYLOR WE SHALL NOT FORGET! In memory of those who perished in the Holocaust, and in tribute to those who survived and those who helped them YOM HASHOAH, HOLOCAUST REMEMBRANCE COMMEMORATION (Virtual) APRIL 8—7:00 P.M. In partnership with the Flint Institute of Music Midwest premier of “In Memory Of…..” by Yale Strom featuring FSO Quartet. OUR PEOPLE Mazel Tov to Michael and Noel Midler (and Linda OUR DEEPEST CONDOLENCES TO THE FAMILY OF Midler, grandmother ) on the birth of their daughter, MIKHAIL KURKIS Mirial Aviv, born Feb 8, 2021 weighing 6 lbs 5 oz. MAY HIS MEMORY BE FOR A BLESSING! 4 April—Zoom Calendar Sunday Monday Tuesday Wednesday Thursday Friday Saturday 1 2 3 4 5 6 7 8 9 10 YOM HASHOAH PROGRAM IN PARTNER- SHIP WITH F.I.M. @ 7:00 P.M. 11 12 13 14 15 16 17 YOM HA’ATZMAUT ACROSS AMERICA @ 2 P.M. E.T. 18 19 20 21 22 23 24 25 26 27 28 29 30 FJF BOARD LAG B’OMER MEETING @ 5:30 P.M. LOOKING AHEAD TO MAY Please email any information to be published MAY 2—23 in the next Jewish Reporter to Ashley Musser 17th Annual Karen Schneider Jewish Film Festival (with generous funding at [email protected] or call the by the Ravitz Foundation) FJF office 810-767-5922. MAY 13—6:00 P.M. Space Torah Project Virtual Presentation followed by Q & A with astronaut, Next Reporter deadline is April 21st. Dr. Jeffrey Hoffman 5 Albert Bourla-Pfizer Vaccine Sixty thousand Jews lived in Thessaloniki, Greece on the Pfizer company where he became 'Head of Global eve of the outbreak of World War II - Vaccines'. From there, he soon became the CEO of Pfizer A living and vibrant Jewish community. Most of the porters in 2019. Throughout the past year, Dr. Bourla led the in the port of Thessaloniki were Jews. The port of company's efforts to find a vaccine for the new coronavirus Thessaloniki was even closed on Saturday. Great rabbis in a super effort. lived there as well. The Nazi terror brutally rose against this The vaccine that will save the lives of millions of people glorious community. Hitler took Greece by storm to secure around the world was led and pushed by a Jew – the son his southern wing before launching Operation Barbarossa of Holocaust survivors. From Thessaloniki. His vaccine will and the Nazi offensive against Russia. also reach Germany, where thousands have died from Out of 60,000 Thessaloniki Jews, about 50,000 were Covid-19, and the vaccine will also save lives there. exterminated in Birkenau in a very short time. Few survived. And this is why Israel is becoming the first country to Among the survivors was the Bourla family. receive the vaccine. In memory of Albert’s grandparents. After the war in 1961 a son was born to the Bourla family. To cap this incredible story, Pfizer executives, including its And they named him Israel - Abraham. (Albert). Albert grew CEO Albert Bourla, won't "cut the line" to get a COVID-19 up and studied veterinary medicine. He received his vaccine, Bourla told CNBC on Monday, saying “I'm 59 years doctorate in reproductive biotechnology from the Aristotle old, in good health, I'm not working on the frontline, so my University of Salonika Veterinary School. At the age of 34 type it is not recommended to get vaccination now." He is he moved to the United States. waiting his turn in order to save as many other people He married a Jewish woman named Miriam and had two whose lives are in greater jeopardy. children. In the United States, Bourla was integrated into the What a Mensch! medical industry. He progressed very quickly and joined the Michiganders can now begin registering for the COVID-19 vaccination clinic at Ford Field in Detroit The Ford Field site will operate from 8 a.m.
Recommended publications
  • Pfizer's Bourla
    No. 3985 December 13, 2019 line success and business development. “In the next two years, we need to see how the pipeline is delivering,” he said. Bourla has been outspoken that when it comes to business development, he doesn’t see a mega-merger on the hori- zon. Instead, he said he is looking to bring in mid-stage clinical development assets to complement the internal pipeline. It sounds like investors can expect the company to be active on the business development front within those guard- rails. “I want to double it,” he said of the pipeline, which includes 92 projects right now. “And, we are going to double it by bringing in a lot of innovation to comple- ment what we distribute.” The company is focusing business de- velopment on six core therapeutic areas Pfizer’s Bourla: “I Think We Forgot as well, but Bourla indicated the company will be actively building out those areas both through internal investment and What It Looks Like To Grow” external collaboration. “We’re going to be JESSICA MERRILL [email protected] active because Pfizer is a very big plane and it cannot fly with one engine,” he said. fizer Inc. CEO Albert Bourla took in July it will merge the Upjohn business Bourla highlighted Pfizer’s recent acqui- over the top leadership spot from with Mylan NV to form a new generic drug sition of the cancer specialist Array Bio- PIan Read a year ago, but has quickly company to be called Viatris GMBH. Pharma for $11.4bn as an example of the executed on big changes poised to make The resulting Pfizer will be significantly kinds of deals the company will be pursu- Pfizer significantly smaller and faster smaller, with a 2020 annual revenue base ing.
    [Show full text]
  • How Jews Change the World - the Jerusalem Post
    1/7/2021 How Jews change the world - The Jerusalem Post Jerusalem Post > Opinion How Jews change the world It comes as no surprise that two Jews, Bourla and Zaks, are spearheading two COVID- 19 vaccines to which many may one day soon owe their lives. By SHLOMO MAITAL DECEMBER 22, 2020 12:28 8000 British author Norman Lebrecht faces the media holding his Whitbread Book of the Year Award entry, 'The Song of Names,' in London in 2003. (photo credit: REUTERS) Advertisement ~ Listen to this article now \l:V 09:18 Powered by Trinity Audio https://www.jpost.com/jerusalem-report/how-jews-change-the-world-652199 1/6 1/7/2021 How Jews change the world - The Jerusalem Post Report~ A Greek Jew, two Turkish-born Germans, a Lebanese Armenian and an Israeli walk into a bar. Actually - not a bar, but a research lab. And it's not a joke. It's about brilliant people, all of them emigres, some Jewish, whose vaccines will hopefully save countless lives in Israel and the world. And there is a back story - about a century of Jewish genius that changed the world. It is recounted brilliantly by Norman Lebrecht, a British journalist and novelist, and graduate of Bar-llan University, in his book Genius and Anxiety: HowJews Changed the World, 1847-1947. Let's begin with the vaccine. On Friday, November 13, Prime Minister Benjamin Netanyahu signed a deal with the giant US pharmaceutical company Pfizer to purchase millions of coronavirus vaccine doses. It was only days after Pfizer announced clinical trials showed the vaccine was 90% effective at preventing COVID-19.
    [Show full text]
  • Pfizer and Biontech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa
    Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa July 21, 2021 NEW YORK and MAINZ, GERMANY, July 21, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the signing of a letter of intent with The Biovac Institute (Pty) Ltd, known as “Biovac”, a Cape Town-based, South African biopharmaceutical company, to manufacture the Pfizer-BioNTech COVID-19 vaccine for distribution within the African Union. Biovac will perform manufacturing and distribution activities within Pfizer’s and BioNTech’s global COVID-19 vaccine supply chain and manufacturing network, which will now span three continents and include more than 20 manufacturing facilities. To facilitate Biovac’s involvement in the process, technical transfer, on-site development and equipment installation activities will begin immediately. Pfizer and BioNTech expect that Biovac’s Cape Town facility will be incorporated into the vaccine supply chain by the end of 2021. Biovac will obtain drug substance from facilities in Europe, and manufacturing of finished doses will commence in 2022. At full operational capacity, the annual production will exceed 100 million finished doses annually. All doses will exclusively be distributed within the 55 member states that make up the African Union. “From day one, our goal has been to provide fair and equitable access of the Pfizer-BioNTech COVID-19 vaccine to everyone, everywhere,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “Our latest collaboration with Biovac is a shining example of the tireless work being done, in this instance to benefit Africa. We will continue to explore and pursue opportunities to bring new partners into our supply chain network, including in Latin America, to further accelerate access of COVID-19 vaccines.” “We aim to enable people on all continents to manufacture and distribute our vaccine while ensuring the quality of the manufacturing process and the doses,” said Ugur Sahin, M.D., CEO and Co-founder of BioNTech.
    [Show full text]
  • Proxy Statement 2021
    Purpose Blueprint OUR PURPOSE Breakthroughs that change patients’ lives OUR BOLD MOVES 1. Unleash the 2. Deliver 3. Transform our 4. Win the 5. Lead the power of our first-in-class go-to-market digital race conversation people science model in pharma OUR BIG IDEAS 1.1 Create room for 2.1 Source the best 3.1 Improve access 4.1 Digitize drug 5.1 Be known as the meaningful work science in the through new payer discovery and most patient- 1.2 Recognize both world partnerships development centric company leadership and 2.2 Double our 3.2 Address the 4.2 Enhance health 5.2 Drive pro- performance innovation success patient outcomes and innovation/pro- 1.3 Make Pfizer an rate affordability patient experience patient policies amazing 2.3 Bring medicines to challenge 4.3 Make our work 5.3 Focus the narrative workplace for all the world faster 3.3 Transform the way faster and easier on the value of our we engage science patients and physicians OUR VALUES Courage Excellence Equity Joy A Letter from Pfizer’s Chairman & Chief Executive Officer To Our Shareholders: 2020 was a year like none other in Pfizer’s history – defined by bold decisions, even bolder actions and incredible results. With the separation of Upjohn, we created a company that was 20% smaller, but more focused than ever on delivering first-in-class science for the benefit of patients. Through our collaboration with BioNTech, we delivered a breakthrough COVID-19 vaccine in less than a year. And by harnessing the power of a variety of digital capabilities – as well as our own steadfast commitment to patients – we made sure that despite lockdowns and travel restrictions, we continued to reach more than 400 million patients worldwide with our medicines and vaccines.
    [Show full text]
  • Pfizer and Biontech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
    Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents May 11, 2021 In a Phase 3 trial, the vaccine was 100% effective and generally well tolerated in participants aged 12 to 15 years Data also submitted to European Medicines Agency (EMA) and other global regulators, with additional authorizations expected in coming weeks NEW YORK and MAINZ, GERMANY, May 11, 2021 —Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for their COVID-19 vaccine to include individuals 12 to 15 years of age. This is the first COVID-19 vaccine authorized in the U.S. for use in this age group. “Today’s expansion of our EUA represents a significant step forward in helping the U.S. government broaden its vaccination program and help protect adolescents before the start of the next school year,” said Albert Bourla, Chairman and Chief Executive Officer, Pfizer. “We are grateful to all of our clinical trial volunteers and their families, whose courage helped make this milestone possible. Together, we hope to help bring a sense of normalcy back to young people across the country and around the world.” The FDA based its decision on data from a pivotal Phase 3 clinical trial, which enrolled 2,260 participants aged 12 to 15 years. Topline results from this trial, announced on March 31, 2021, showed a vaccine efficacy of 100% in participants with or without prior SARS-CoV-2 infection and robust antibody responses.
    [Show full text]
  • April 16, 2021
    April 16, 2021 Dear <<First Name>>, Welcome to this week's issue of the California Pharmacists Association's CEO Message. IN THIS ISSUE Emerging Role of Pharmacists on the Front Line of Vaccine Administration Now that we have been at the front and center of this whole vaccine for COVID-19 and its protocols, the role of pharmacists as a frontline vaccinator and administration has really emerged with this pandemic. [Read Article] Burnout and the Challenges Facing Pharmacists during COVID-19: Results of a National Survey Background COVID-19 has impacted the psychological wellbeing of healthcare workers and has forced pharmacists to adapt their services. [Read Article] Joint CDC and FDA Statement on Johnson & Johnson COVID-19 Vaccine As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. [Read Article] How Pharmacists Can Protect Patients from Outdated COVID-19 Treatment Hydroxychloroquine is an ineffective and potentially dangerous treatment for COVID-19, yet prescriptions for patients with the virus continue. [Read Article] Pfizer CEO says Third Shot Likely Needed Within 12 Months People will probably need a third shot of the Pfizer/BioNTech within 12 months of being fully vaccinated, Pfizer CEO Albert Bourla told CNBC on Thursday. Annual shots may also be needed, Bourla said. [Read Article] Tabula Rasa HealthCare Expands COVID-19 Vaccine Support Services to Community Pharmacies Tabula Rasa HealthCare, Inc., a leading healthcare technology company advancing the safe use of medication, today announced an expansion of COVID-19 services for independent and chain pharmacies.
    [Show full text]
  • Just a Nosh..Just
    St. Petersburg, FL 33707 St. Petersburg, FL Avenue 6416 Central Tampa Jewish Press of Inc. Bay, Tampa The Jewish Press Group of www.jewishpresstampa.com VOL.33, NO. 9 TAMPA, FLORIDA A NOVEMBER 20 - DECEMBER 3, 2020 12 PAGES Pompeo visits settlements; sets policy on BDS, ‘made in Israel’ (JTA) – Mike Pompeo became the Pompeo also said that the Trump ad- first U.S. secretary of state to visit both ministration will cut ties with any The Jewish Press Group an Israeli settlement in the West Bank groups that support the boycott Is- PAID U.S. POSTAGE of Tampa Bay, Inc. Bay, Tampa of PRESORTED and the Golan Heights, a disputed area rael movement, (commonly known STANDARD on Israel’s border with Syria that the as Boycott, Divestment, Sanctions Trump administration has recognized movement or BDS) which the U.S. as part of Israel. will officially consider anti-Semitic. Twitter Pompeo Mike Photo At a news conference Thursday, Later in the day, he visited the Secretary of State Mike Pompeo leads a delegation to the Nov. 19, in Jerusalem with Israeli Psagot winery in a settlement near West Bank town of Qasr al-Yahud, the site where tradition Prime Minister Benjamin Netanyahu, POMPEO continued on PAGE 11 holds that Jesus was baptized. VACCINE HEROES JustJust aaJTA newsnosh..nosh.. service In-person Hanukkah party planned at White House Israeli scientist Immigrant helps make WASHINGTON – The White House is throwing an in- person Hanukkah party, one of a series of recent events at Moderna history with Pfizer’s vaccine the Trump administration has held despite coronavirus concerns.
    [Show full text]
  • Report from Accountable.US
    NEW ANALYSIS REVEALS $250M IN INSIDER PROFITEERING AT GOVERNMENT-BACKED DRUG COMPANIES, INCLUDING $105M IN NEW TRADES IN LESS THAN 3 MONTHS’ TIME In Six Months Since Launch Of Operation Warp Speed, Execs At Five Drug Companies Made Net Profit Of More Than $250 Million Dumping Their Companies’ Stocks. An earlier report from Accountable.US compiled executive trading data from the launch of Operation Warp Speed on May 15 through August 31, 2020 and found they made stock transactions valued at a net profit of more than $145 million. New analysis of insider transactions at those companies over the six months between May 15 and November 15, 2020, show more than $250 million in net profit. Company Net Profit Emergent BioSolutions $23,906,515.14 Johnson & Johnson $4,276,630.00 Moderna $165,889,439.69 Novavax $46,372,082.90 Pfizer $10,490,165.85 Total $250,934,833.57 From September To Mid-November, Execs At Four Drug Companies Involved In Operation Warp Speed Have Made Net Profit Of More Than $105M Dumping Their Companies’ Stock. According to SEC filings, from the beginning of September through November 15, 2020, executives and directors at four of the companies receiving COVID vaccine funding through Operation Warp Speed have made stock transactions valued at a net profit of more than $105 million. NOTE: Johnson & Johnson did not report any new individual insider transactions during this period. Company Net Profit Emergent BioSolutions $18,860,527.37 Moderna $50,406,146.77 Novavax $29,037,668.05 Pfizer $7,388,569.80 Total $105,692,911.99 • The net profit of these transactions from May 15-November 15, 2020 was $250.9 million; the total profit of these trades was $292.1 million.
    [Show full text]
  • April 28, 2021
    American Nephrology Nurses Association Daily Capitol Hill Update – Wednesday, April 28, 2021 The following information comes from directly from news sources including Bloomberg Government, Kaiser Health News, and other news sources. Schedules: White House and Congress WHITE HOUSE • 9:00 PM: President Biden addresses a joint session of Congress. CONGRESS: • The Senate is set to take up a measure today that would reinstate an Obama-era rule limiting harmful methane emissions from oil and gas drilling. • The Senate Judiciary Committee’s initial hearing for Biden’s first judicial nominations, including D.C. Circuit nominee Ketanji Brown Jackson, will take place today. Congressional, Health Policy, and Political News • Bloomberg Government: Medicare Age Eligibility: Biden’s new American Families Plan calls for the lowering of the age to 60 for people to voluntarily enroll in Medicare, according to a White House fact sheet. Congressional Democrats have supported such a move, and want to help fund the benefits expansion with $456 billion that Medicare could save over 10 years through Biden’s plan to let the program negotiate its own drug prices. o After the massive loss of jobs and employer-based health coverage due to Covid- 19, Democrats say public support for their plan is strong. A recent Gallup poll found roughly 46 million Americans couldn’t pay for quality health care if they needed it. And even before the pandemic struck, 77% of Americans, including 69% of Republicans, favored letting adults ages 50 to 64 buy into the Medicare program, according to a January 2019 poll by the Kaiser Family Foundation.
    [Show full text]
  • PFIZER INC. (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-3619 PFIZER INC. (Exact name of registrant as specified in its charter) Delaware 13-5315170 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) 235 East 42nd Street, New York, New York 10017 (Address of principal executive offices) (zip code) (212) 733-2323 (Registrant’s telephone number, including area code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $.05 par value PFE New York Stock Exchange 0.000% Notes due 2020 PFE20A New York Stock Exchange 0.250% Notes due 2022 PFE22 New York Stock Exchange 1.000% Notes due 2027 PFE27 New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐ Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒ Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
    [Show full text]
  • Evolve- AMERICAS Stage Agenda
    AMERICAS STAGE 11am - 3pm EDT 3pm – 7pm GMT Stakeholder Earth: Two Icons Push for a Sustainable Planet As corporations enter the fray of societal change more than ever before, more is being asked of CEOs when it comes to making decisions and speaking out on issues that were once thought to not be in their scope. From climate change and sustainability, DEI to even the role of business when it comes to political change, leaders now consider the long-term impact their business will have on the world. We speak to two CEOs of household-name companies: James Quincey of Coca-Cola and Kasper Rorsted of Adidas on sustainability, the growing role of the CEO and how they are evolving their strategies for long-term change. James Quincey, Coca-Cola CEO Kasper Rorsted, Adidas CEO Interviewed by: Sara Eisen, CNBC “Closing Bell” Co-Anchor Game Changer: How Vaccine Innovation Will Impact the Future of Health Pfizer’s development and production of its Covid-19 vaccine not only helped pave the way to reopen the economy, but also could be a game changer in terms of future medical developments. CEO Albert Bourla joins us on what may be a turning point in science and medicine. Albert Bourla, Pfizer CEO Interviewed by: Andrew Ross Sorkin, CNBC “Squawk Box” Co-Anchor CRISPR Revolution: The Future of Genetic Engineering Biochemist Jennifer Doudna is best known for her pioneering work in CRISPR gene editing, for which she was awarded the 2020 Nobel Prize in chemistry. She’s also a leading biotech entrepreneur, with several life science start-ups under her belt.
    [Show full text]
  • Albert Bourla Chairman & Chief Executive Officer
    Albert Bourla Chairman & Chief Executive Officer Pfizer Confidential 1 Forward-Looking Statements and Other Notices Our discussions during Pfizer’s Investor Day include forward-looking statements about our anticipated future operating and financial performance, business plans and prospects; expectations for our product pipeline, in-line products and product candidates, including anticipated regulatory submissions, data read- outs, study starts, approvals, revenue contribution, growth, performance, timing of exclusivity and potential benefits; manufacturing and product supply; our efforts to respond to COVID-19, including our investigational vaccine candidate against SARS-CoV-2 and our investigational protease inhibitor, and our expectations regarding the impact of COVID-19; our ability to successfully capitalize on growth opportunities and prospects; plans for and prospects of our acquisitions and other business development activities, including our proposed transaction with Mylan N.V. (Mylan) to combine Upjohn and Mylan to create a new global pharmaceutical company; plans relating to share repurchases and dividends; and other statements about our business, operations and financial results that are each subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Among other things, statements regarding revenue and earnings per share growth; the development or commercial potential of our product pipeline, in-line products, product candidates and
    [Show full text]